Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Milan, M.G.L"'
Autor:
Lasaponara, F, Paradiso, M, Milan, M.G.L, Morabito, F, Sedigh, O, Graziano, M.E *, Abbona, A, Piccoli, G.B, Rossetti, M, Mezza, E, Ferrando, U
Publikováno v:
In Transplantation Proceedings April 2004 36(3):502-504
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kakogiannos N; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Ferrari L; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Giampietro C; EMPA, Swiss Federal Laboratories for Material Science and Technologies, Experimental Continuum Mechanics, Dübendorf, Switzerland (C.G.)., Scalise AA; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Maderna C; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Ravà M; Experimental Oncology (M.R.), European Institute of Oncology IRCSS, Milan., Taddei A; Benevolent AI, London, United Kingdom (A.T.)., Lampugnani MG; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.).; Mario Negri Institute for Pharmacological Research, Milan (M.G.L.)., Pisati F; Cogentech SRL Benefit Corporation, Milan (F.P.)., Malinverno M; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Martini E; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Costa I; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Lupia M; Unit of Gynaecological Oncology Research (M.L., U.C.), European Institute of Oncology IRCSS, Milan., Cavallaro U; Unit of Gynaecological Oncology Research (M.L., U.C.), European Institute of Oncology IRCSS, Milan., Beznoussenko GV; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Mironov AA; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.)., Fernandes B; Pathology Unit, Humanitas Clinical and Research Centre, Rozzano, Milan (B.F., N.R.)., Rudini N; Pathology Unit, Humanitas Clinical and Research Centre, Rozzano, Milan (B.F., N.R.)., Dejana E; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.).; Oncology and Haemato-Oncology, School of Medicine, University of Milan (E.D.).; Immunology, Genetics and Pathology, Uppsala University, Sweden (E.D.)., Giannotta M; From the FIRC Institute of Molecular Oncology, Milan, Italy (N.K., L.F., A.A.S., C.M., M.G.L., M.M., E.M., I.C., G.V.B., A.A.M., E.D., M.G.).
Publikováno v:
Circulation research [Circ Res] 2020 Sep 25; Vol. 127 (8), pp. 1056-1073. Date of Electronic Publication: 2020 Jul 15.